This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

D3_SPLEENDISEASE

Abscess of spleen

Endpoint Browser

D3_ABSCESSSPLEEN

No definition available.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D73.3 Hospital discharge: ICD-8 — 28940 Cause of death: ICD-10 — D73.3 Cause of death: ICD-8 — 28940 2 out of 7 registries used, show all original rules.	24
4. Check minimum number of events None	24
5. Include endpoints None	24
6. Filter based on genotype QC (FinnGen only)	24

Control definitions (FinnGen only)

Control exclude: D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D73
Name in latin: Abscessus lienis

NAME	D3_ABSCESSSPLEEN
CONTROL_EXCLUDE	D3_BLOODOTHER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D733
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	28940
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D733
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	28940
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Abscess of spleen based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	241	112	126
Only index persons	195	96	99
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	61.71	64.23	59.49
Only index persons	59.84	62.88	56.90

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24	12	12
Unadjusted period prevalence (%)	0.00	0.00	0.01
Median age at first event (years)	66.68	67.49	65.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

12.41

7.18

5.3

1.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

18.97

5.53

21.8

5.2

9.8

9.6

mmol/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

9.52

4.48

1.8

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5.32

3.84

2.3

1.6

915.4

1212.1

nmol/l

—

(42870588) Differential panel, method unspecified - Blood

4.37

3.08

8.6

6.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6.56

2.98

2.9

2.6

0.3

0.2

g/l

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

6.56

2.98

12.1

1.9

5.7

4.9

kpa

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4.29

2.93

3.4

2.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

10.07

2.88

1.6

1.0

—

(40768804) Tissue Pathology biopsy report

4.02

2.68

2.5

2.0

—

(3022313) Gas panel - Capillary blood

7.52

2.49

15.8

1.9

—

(3000494) Fungus identified in Specimen by Culture

4.74

2.36

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4.95

2.19

2.0

1.5

—

(3022145) Colonoscopy Study observation

3.61

2.02

1.3

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.86

1.98

3.4

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3.35

1.87

3.4

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3.05

1.83

5.9

2.1

71.7

54.1

u/l

0.63

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.55

1.81

1.6

1.2

—

(3026008) Bacteria identified in Urine by Culture

2.81

1.58

3.7

3.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3.66

1.52

2.2

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3.43

1.43

3.6

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

2.58

1.36

7.0

1.9

—

(4035726)

3.22

1.36

1.2

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2.85

1.34

2.0

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2.55

1.33

2.6

2.0

87.4

106.6

pmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2.49

1.31

10.1

3.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3.04

1.28

3.0

3.1

1.0

0.0

e6/l

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2.73

1.27

3.0

2.2

25.9

30.3

—

(40768797) Stomach Pathology biopsy report

2.76

1.23

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

2.52

1.22

7.1

3.5

98.6

88.3

—

(3000850) Epithelial cells [#/volume] in Urine

2.45

1.20

1.4

2.5

15.9

4.3

e6/l

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2.46

1.18

2.1

1.5

15.7

25.6

nmol/l

—

(3003694) ABO and Rh group [Type] in Blood

2.33

1.16

1.4

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2.33

1.12

7.3

2.3

285.3

120.2

ug/l

1.37

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.22

1.11

6.3

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

143

2.57

1.11

7.7

5.1

—

(3013512) EKG study

2.33

1.09

4.2

5.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

102

2.25

1.08

3.4

2.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

102

2.25

1.08

27.1

5.3

1.2

mmol/l

0.25

(36304419) Bacteria [Presence] in Urine

2.01

0.87

2.0

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1.84

0.66

5.3

4.7

—

(3044889) 12 lead EKG panel

138

1.79

0.56

5.4

3.8

—

(1761868) Lipid panel - Serum or Plasma

1.52

0.45

2.8

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

163

1.79

0.45

46.6

14.8

39.8

40.2

0.08

112

(21494755) Public health laboratory ask at order entry panel

0.00

0.43

0.0

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.52

0.39

1.5

5.7

—

(40758558) Short blood count panel - Blood

1.44

0.37

7.0

9.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.54

0.35

2.9

3.5

7095.2

2024.1

ng/l

—

(4094501)

0.00

0.22

0.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.00

0.22

0.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.00

0.22

0.0

1.0

—

(4034850)

0.00

0.22

0.0

5.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.00

0.20

0.0

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1.33

0.17

5.1

4.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

6.3

—

4.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

6.3

—

63.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.00

0.0

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.00

0.0

2.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.0

1.4

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.6

—

(1002224) Polysomnography panel

0.00

0.0

1.0

—

(3020891) Body temperature

0.00

0.0

3.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

2.1

—

16.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.0

1.3

—

291.4

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.0

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_ABSCESSSPLEEN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have D3_ABSCESSSPLEEN.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: D3_ABSCESSSPLEEN – Abscess of spleen

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Abscess of spleen

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints